Ireland
--:--IST
Latest
Recruiting Observational

Registry of Multiple Osteochondromas

NCT04133285 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2013-06-28
Last updated
2025-11-20

Condition(s) studied

Multiple Osteochondromas

Study summary

REM is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc.

This approach has been developed to corroborate and integrate data from different sources evaluating several aspects of diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate disease pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * All Multiple Osteochondromas patients, including prenatal diagnosis of Multiple Osteochondromas Exclusion Criteria: * Any condition unrelated to Multiple Osteochondromas

Primary outcome measure(s)

  • Natural History and Epidemiology in terms of clinical, genetic and functional evaluation — 25 years
    To maintain an established registry in order to assess epidemiology and natural history. Collection of: 1. physical examinations data: assessment of severity of the disease (according to Mordenti et al classification) 2. orthopedic and functional data: stature (cm), weight (kg), number and localization of sites affected, site of malignant transformation, definition of deformities (localization and number), definition of limitations (localization and number) 3. surgical procedures: type, number and site of surgeries disease-related and age at surgeries 4. genetics background: target gene, type of mutation, type of variant detected, clinical significance 5. family history: inheritance 6. treatment information: pharmacological, devices, supplements, and other treatments All the features are updated at each follow up. Clinical reports, medical charts, genetic report and imaging are the primary sources of data

Trial sites (1)

FacilityCityRegionStatus
Irccs Istituto Ortopedico Rizzoli Bologna Emilia-Romagna Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04133285 on ClinicalTrials.gov ↗ ← All trials in Italy